281 – 290 of 2295
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Sequence-specific 2'-O-methoxyethyl antisense oligonucleotides activate human platelets through glycoprotein VI, triggering formation of platelet-leukocyte aggregates
- Contribution to journal › Article
-
Mark
Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors : Follow-up of patients diagnosed 2002–2017 in a complete coverage and nationwide agnostic register study
- Contribution to journal › Article
-
Mark
Single base substitution and insertion/deletion mutational signatures in adult core binding factor acute myeloid leukemia
(2022) In Leukemia
- Contribution to journal › Letter
-
Mark
Clinical outcome and adherence rate in Scandinavian patients with intermediate-intensity prophylaxis before and after the switch of standard half-life FVIII products to BAY 81–8973
- Contribution to journal › Article
-
Mark
The EHA Research Roadmap : Transfusion Medicine
- Contribution to journal › Debate/Note/Editorial
-
Mark
Immune tolerance induction in the era of emicizumab – still the first choice for patients with haemophilia A and inhibitors?
- Contribution to journal › Article
-
Mark
Associations between hemostatic markers and mortality in COVID-19 - Compounding effects of D-dimer, antithrombin and PAP complex
- Contribution to journal › Article
-
Mark
Rutinmässig screening med APTT är inte indicerad före operation
- Contribution to journal › Scientific review
-
Mark
Novel RHD variant causing RhD negative phenotype identified in a pregnant woman
- Contribution to journal › Debate/Note/Editorial
-
Mark
Critical role of Lama4 for hematopoiesis regeneration and acute myeloid leukemia progression
- Contribution to journal › Article
